Newsroom
Latest News
Immune checkpoint inhibitor atezolizumab as a potential game-changer in the treatment of early-stage NSCLC
Vall d'Hebron Institute of Oncology
2021 Farinella Prize awarded to Diana Valencia and Lena Noack
Europlanet
Tyrosine kinase inhibitor prolongs progression-free survival in rare neuroendocrine tumour
European Society for Medical Oncology
NCI-funded trials network has added 14 million years of life for those with cancer
SWOG Cancer Research Network
News from Other Organiations
ESMO: New drug shows promise in treating early-stage breast cancer
University of California - Los Angeles Health Sciences
Immune checkpoint inhibitor atezolizumab as a potential game-changer in the treatment of early-stage NSCLC
Vall d'Hebron Institute of Oncology
2021 Farinella Prize awarded to Diana Valencia and Lena Noack
Europlanet
Tyrosine kinase inhibitor prolongs progression-free survival in rare neuroendocrine tumour
European Society for Medical Oncology
NCI-funded trials network has added 14 million years of life for those with cancer
SWOG Cancer Research Network